Guilford Pharmaceuticals (MM) News - GLFD

Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA Merger

BALTIMORE, Sept. 29 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) today announced that its stockholders approved the...

MGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting Period

MGI PHARMA, INC. (Nasdaq:MOGN), an oncology and acute care focused biopharmaceutical company, and Guilford Pharmaceuticals Inc. (Nasdaq:GLFD), a...

Guilford Pharmaceuticals Reports 2005 Second Quarter Results

BALTIMORE, Aug. 8 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) today reported financial results for the quarter ended...

Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005

BALTIMORE, Aug. 2 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) will host a conference call and live audio webcast to...

Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005

BALTIMORE, Aug. 2 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc. (NASDAQ:GLFD) will host a conference call and live audio webcast to...

Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy

Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy BALTIMORE, May 24 /PRNewswire-FirstCall/...

Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO

Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO BALTIMORE, May 18...

Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma

Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma Study Suggests Safety of...

AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA

AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA BALTIMORE, May 11 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...

Guilford Pharmaceuticals Reports 2005 First Quarter Results

Guilford Pharmaceuticals Reports 2005 First Quarter Results BALTIMORE, May 9 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005 BALTIMORE, May 2 /PRNewswire-FirstCall/...

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005 BALTIMORE, May 2 /PRNewswire-FirstCall/...

Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program

Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program BALTIMORE, April 21 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy BALTIMORE, April 5 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy BALTIMORE, April 5 /PRNewswire-FirstCall/ -- Guilford Pharmaceuticals...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Guilford Pharmaceuticals (MM) (GLFD)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

GLFD News

Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA Merger

MGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting Period

Guilford Pharmaceuticals Reports 2005 Second Quarter Results

Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005

Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005

Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy

Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO

Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma

AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA

Guilford Pharmaceuticals Reports 2005 First Quarter Results

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005

Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy

GLFD Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Guilford Pharmaceuticals (MM) (GLFD) News

Guilford Pharmaceuticals (MM) (GLFD)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

GLFD News

Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA Merger

MGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting Period

Guilford Pharmaceuticals Reports 2005 Second Quarter Results

Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005

Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005

Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy

Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO

Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma

AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA

Guilford Pharmaceuticals Reports 2005 First Quarter Results

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005

Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005

Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy

Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy

GLFD Discussion

Your Recent History